-
Study aim
-
The study aims to clinically and biochemically assess the effects of Zingiber officinale and Brassica oleracea (cabbage) in patients with Frozen Shoulder.
-
Design
-
A pragmatic, community-based study. A single-blinded, randomized controlled trial with a parallel group design of 375 patients, will enroll between January 2025 to June 2025
-
Settings and conduct
-
The study will be conducted at Muhammad Physiotherapy and Rehabilitation Center, Multan, Pakistan. After approval obtained from the Iranian Registry of Clinical Trial and institutional ethical committee
-
Participants/Inclusion and exclusion criteria
-
Participants diagnosed with frozen shoulder, aged (30- 60 y), limited shoulder r is limited ROM, have experienced pain (NPRS > 4) during movement, and have symptom duration > 3 months will be included in this study. Participants having a history of fracture, infections, inflammatory disorder around the shoulder, any neurological or cardiac conditions, acute or chronic conditions affecting joint mobility, surgical release of capsules, or history of steroidal injection in the affected area will be excluded from this study
-
Intervention groups
-
The patients will be engaged after signing the written consent form. The lottery method will be used for grouping, 375 patients into 3 parallel groups (n=125). Group 1 will be treated with a test herbal gel 5% w/w with phonophoresis with therapeutic ultrasound (frequency of 0.8MH, and an intensity of about 1.5 W/cm2, and with the continuous mode). Group 2 will be treated with the standard drug piroxicam 0.5% w/w with phonophoresis. Group 3 will be treated with therapeutic ultrasound using aqueous gel as coupling media as a placebo or control group. The proprioceptive shoulder mobilization and muscle energy technique (MET) exercises will be used in 3 groups.
-
Main outcome variables
-
Pain, stiffness, range of motion, activities of daily living, and inflammation.